|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 奥维昔巴特>> 市场分析报告 |
奥维昔巴特市场分析报告 |
|
ODEVIXIBAT - Emerging Insight and Market Forecast - 2030 ... available databases. ODEVIXIBAT Analytical Perspective by DelveInsight In-depth ODEVIXIBAT Market ... provides a detailed market assessment of ODEVIXIBAT in Seven Major Markets, i.e., ... the clinical trials information of ODEVIXIBAT covering trial interventions, ... Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus - Drugs in Development by Stages, Target, MoA, RoA, ... Ileal SodiumBile Acid Cotransporter - Pipeline Review, H2 2019 Ileal SodiumBile Acid Cotransporter - Pipeline Review, H2 2019 SUMMARY Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member ... Primary Biliary Cholangitis - Pipeline Insight, 2019 This report can be delivered to the clients within 24 Hours "Primary Biliary Cholangitis - Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of ... Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Sclerosing Cholangitis - Drugs ... Alagille Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major Alagille syndrome markets reached a value of US$ 267.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 435.6 Million by 2034, exhibiting a growth rate (CAGR) of 4.53% during 2024-2034. The Alagille syndrome market has ... Progressive Familial Intrahepatic Cholestasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major progressive familial intrahepatic cholestasis markets are expected to exhibit a CAGR of 4.68% during 2024-2034. The progressive familial intrahepatic cholestasis market has been comprehensively analyzed in IMARC's new report titled "Progressive ... Pruritus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major pruritus markets reached a value of US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.8 Billion by 2034, exhibiting a growth rate (CAGR) of 2.42% during 2024-2034. The pruritus market has been comprehensively ... Cholestatic Pruritus Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 ... inhibitors, and emerging therapies such as odevixibat and maralixibat, which target bile ... Global Liver Disease Treatment Market - 2025 -2033 ... and Welfare has approved Bylvay (odevixibat) for treating pruritus associated with ... Albireo Pharma Inc (ALBO) - Financial and Strategic SWOT Analysis Review ... diseases. Its pipeline products include odevixibat (A4250) intended for treatment of progressive ... |